KPV is a naturally occurring tripeptide fragment derived from the C-terminal end of the alpha-melanocyte-stimulating hormone (α-MSH). It is widely studied for its potent anti-inflammatory, immunomodulatory, and skin barrier-supporting properties, making it a key compound of interest in gastrointestinal, dermatological, and systemic inflammatory research.

KPV has been shown in preclinical and clinical research to:

 Reduce inflammation by inhibiting key pro-inflammatory cytokines (such as TNF-α, IL-1β, and IL-6) and modulating NF-κB signaling pathways.
 Support gut health and mucosal integrity, with studies showing protective effects in models of colitis and other inflammatory bowel conditions.
 Promote skin healing and barrier repair, aiding in wound closure, dermatitis, and inflammation-related skin conditions.
 Modulate immune responses, helping regulate excessive immune activation while maintaining balanced immune defense.
 Potentially assist systemic recovery from chronic inflammation and oxidative stress.